MedTrace Logo

Correlation Between Serum Anti-Müllerian Hormone & Müllerian Ducts Anomalies in Infertility

NCT02436538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 226

Last updated 2016-12-06

No results posted yet for this study

Summary

Anti-Müllerian hormone (AMH), also known as Müllerian inhibiting substance, is a dimeric glycoprotein that belongs to the transforming growth factor-beta family. It is involved in the regression of the Müllerian ducts during male fetal development. In the female, AMH is solely produced by the granulosa cells of preantral and small antral follicles, and regulates ovarian activity and follicular steroidogenesis

Conditions

Interventions

OTHER

Anti Mullerian hormone level; Mullerian duct anomaly type

Diagnosis of Mullerian duct anomaly type Clinically or by Imaging Anti-Müllerian Hormone levels

Sponsors & Collaborators

  • The Egyptian IVF-ET Center

    collaborator OTHER

  • Ahmed M.Kamel

    lead OTHER

Principal Investigators

  • Yahia El-fassial, M.D · consultant

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436538 on ClinicalTrials.gov